Novo Nordisk issued FDA warning letter over adverse event reporting
Go back to Novo Nordisk issued FDA warning letter over adverse event reporting| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 50.56 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $50.56 | 52 Week High | $59.00 | |||
| Open | $50.56 | 52 Week Low | $32.80 | |||
| Day High | $50.56 | P/E | N/A | |||
| Day Low | $50.56 | EPS | $0.00 | |||
| Volume | 143,329 | |||||
